SuperworthBiomea Fusion market cap BMEA
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $43.5M
- Highest close in our data
- $1.4B
- Jun 2023
Biomea Fusion is worth $43.5M at the close on Oct 23, 2026, at $0.60 a share.
That is down 50% over the last year and down 86% over five years.
Its highest close in our data was $1.4B in Jun 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $43.5M | $43.5M | $159.8M | −53% |
| 2025 | $93.3M | $54.1M | $159.8M | −36% |
| 2024 | $145M | $145M | $659.5M | −72% |
| 2023 | $518.4M | $207.2M | $1.4B | +109% |
| 2022 | $247.8M | $87.3M | $389M | +15% |
| 2021 | $216.4M | $209.7M | $592.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Biomea Fusion's size, closest first, today.
| Company | Market cap |
|---|---|
| BMEABiomea Fusion | $43.5M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $69M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Biomea Fusion
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.